AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
Investors who purchased the Company's securities between
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Agilon released guidance for 2026 that it knew or should have known was beyond its reach. The Company overstated the impact of its "strategic actions" to reduce risk. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Agilon, investors suffered damages.
Join the case to recover your losses
This press release may be considered
CONTACT:
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/agl-investors-have-opportunity-to-lead-agilon-health-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302699324.html
SOURCE